Ethical dilemmas in clinical research

Psychopharmacology Bulletin

Volumn 32, Issue 1, 1996, Pages 15-17

  Detre, Thomas ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

controlled clinical trials; ethical issues

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; NEUROLEPTIC AGENT;

ANXIETY NEUROSIS; CLINICAL PROTOCOL; CLINICAL RESEARCH; CLINICAL TRIAL; CONFERENCE PAPER; DEPRESSION; DRUG EFFICACY; DRUG SAFETY; HUMAN; INFORMED CONSENT; MEDICAL ETHICS; NEUROPSYCHIATRY; PATIENT RIGHT; PATIENT SELECTION; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA;

BIOMEDICAL AND BEHAVIORAL RESEARCH;

ETHICS, MEDICAL; ETHICS, RESEARCH; EVALUATION STUDIES; HUMAN EXPERIMENTATION; HUMANS; RANDOMIZED CONTROLLED TRIALS;

EID: 0030004269     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (2)

1. Post, N. "Ethical Principles of Human Clinical Therapeutic Trials." Presented at the 35th Annual Meeting of the New Clinical Drug Evaluation Unit (NCDEU), Orlando, FL, June 1, 1995.
2. Pratt, CM, and Moye, LA. The Cardiac Arrhythmia Suppression Trial: Background, interim results and implications. Am. J. Cardiol. 65:20B-29B, 1990.